lung-cancer

Documents about lung-cancer

• Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients#444880ClinicalTrials.gov
• Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer#366603ClinicalTrials.gov
• Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study#373610ClinicalTrials.gov
• DIAGNOSIS, TREATMENT AND OUTCOME OF LUNG CANCER PATIENTS#245497ClinicalTrials.gov
• Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer#426778ClinicalTrials.gov
• I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy#136313ClinicalTrials.gov
• Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer#311135ClinicalTrials.gov
• Lung Cancer Vaccine Plus Oral Dietary Supplement#373589ClinicalTrials.gov
• Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study#394774ClinicalTrials.gov
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening#6911OpenAlex
• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer#143570ClinicalTrials.gov
• Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)#238101ClinicalTrials.gov
• Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients#18603ClinicalTrials.gov
• Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients#217020ClinicalTrials.gov
• Molecular Analysis and Treatment Options of SCLC#238128ClinicalTrials.gov
• Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers#121340ClinicalTrials.gov
• Metformin in Non Small Cell Lung Cancer (NSCLC)#18575ClinicalTrials.gov
• A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer#426769ClinicalTrials.gov
• Pneumonitis After Radiotherapy for Lung Cancer#369849ClinicalTrials.gov
• Safety and Efficiency of γδ T Cell Against Lung Cancer#201795ClinicalTrials.gov
• Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer#356465ClinicalTrials.gov
• Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer#414481ClinicalTrials.gov
• Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer#121343ClinicalTrials.gov
• Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer#394753ClinicalTrials.gov
• Palliative Thoracic ImmunoRT#387138ClinicalTrials.gov
• Lung Cancer Organoids and Patient Derived Tumor Xenografts#407743ClinicalTrials.gov
• A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence#343683ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer#141103ClinicalTrials.gov
• M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers#390925ClinicalTrials.gov
• D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)#349957ClinicalTrials.gov
• Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer#398316ClinicalTrials.gov
• ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy#366614ClinicalTrials.gov
• Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial#28327ClinicalTrials.gov
• Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer#172411ClinicalTrials.gov
• Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity#195321ClinicalTrials.gov
• Inhaled mRNA Tumor-associated Antigen Dry Powder Vaccine in Advanced Lung Cancer and Lung Metastasis of Solid Tumors.#154756ClinicalTrials.gov
• A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer#201596ClinicalTrials.gov
• Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings#254038HAL (France)
• Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC#184838ClinicalTrials.gov
• DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer#125821ClinicalTrials.gov
• Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in Japan#338827OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer#373617ClinicalTrials.gov
• EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER#407717ClinicalTrials.gov
• Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative#148766ClinicalTrials.gov
• Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer#245508ClinicalTrials.gov
• KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer#411388ClinicalTrials.gov
• Pembrolizumab + Idelalisib for Lung Cancer Study#307454ClinicalTrials.gov
• Bronchoscopic Cryo-Immunotherapy of Lung Cancer#369824ClinicalTrials.gov
• SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes#377353ClinicalTrials.gov
• Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer#158112ClinicalTrials.gov

Related topics